Kala Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $39,153,000.
Profit Margin
| 2014 | 455K | -19.36M | -4255.16% |
|---|---|---|---|
| 2015 | 45K | -16.68M | -37071.11% |
| 2016 | 0 | -33.16M | |
| 2017 | 0 | -42.21M | |
| 2018 | 0 | -66.73M | |
| 2019 | 6.07M | -101.98M | -1679.03% |
| 2020 | 6.36M | -112.00M | -1760.52% |
| 2021 | 11.24M | -152.29M | -1354.95% |
| 2022 | 3.89M | -223K | -5.73% |
| 2023 | 0 | -42.19M |
0JQ2.L Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 3.89M | 11.24M | 6.36M | 6.07M | 0 | 0 | 0 | 45K | 455K |
Cost of revenue | 303K | 2.56M | 4.09M | 3.17M | 2.00M | 0 | 643K | 0 | 0 | 455K |
Gross profit | -303K | 1.33M | 7.14M | 3.18M | 4.06M | 0 | -643K | 0 | 45K | 0 |
Operating exp. | ||||||||||
Research and development | 18.58M | 17.65M | 11.51M | 18.35M | 27.27M | 29.29M | 29.00M | 25.02M | 11.38M | 13.85M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 39.15M | 82.68M | 116.57M | 99.42M | 92.29M | 64.72M | 39.87M | 32.66M | 15.99M | 17.99M |
Operating income | -39.15M | -81.35M | -109.43M | -96.23M | -88.22M | -64.72M | -39.87M | -32.66M | -15.94M | -17.84M |
Other income (expenses), net | -3.04M | 36.53M | -33.17M | -8.09M | -6.12M | -390K | -2.33M | 122K | -736K | -1.52M |
Income before tax | -42.19M | -44.82M | -142.60M | -104.32M | -94.34M | -66.73M | -42.21M | -33.16M | -16.68M | -19.36M |
Income tax expense | 0 | -44.59M | 9.69M | 7.67M | 7.63M | 1.29M | 732K | 767K | 604K | 0 |
Net income | -42.19M | -223K | -152.29M | -112.00M | -101.98M | -66.73M | -42.21M | -33.16M | -16.68M | -19.36M |
Earnings per share | ||||||||||
Basic EPS | -17.35 | -0.15 | -116.79 | -106.92 | -149.06 | -124.73 | -305.74 | -95.95 | -48.26 | -40.03 |
Diluted EPS | -17.35 | -0.15 | -116.79 | -106.92 | -149.06 | -124.73 | -305.74 | -95.95 | -48.26 | -40.03 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |